BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2302188)

  • 1. Investigation of the structural basis of the interaction of calpain II with phospholipid and with carbohydrate.
    Crawford C; Brown NR; Willis AC
    Biochem J; 1990 Jan; 265(2):575-9. PubMed ID: 2302188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the active site of m-calpain and the interaction with calpastatin.
    Crawford C; Brown NR; Willis AC
    Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):135-42. PubMed ID: 8250833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the interaction of m-calpain with phospholipids: calpain-phospholipid interactions.
    Arthur JS; Crawford C
    Biochim Biophys Acta; 1996 Apr; 1293(2):201-6. PubMed ID: 8620030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of the carboxyl-terminal region of phospholipase C-beta 1 by calpain abolishes activation by G alpha q.
    Park D; Jhon DY; Lee CW; Ryu SH; Rhee SG
    J Biol Chem; 1993 Feb; 268(5):3710-4. PubMed ID: 8429045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a Ca2+-independent association between calpain II and phospholipid vesicles.
    Garret C; Cottin P; Dufourcq J; Ducastaing A
    FEBS Lett; 1988 Jan; 227(2):209-14. PubMed ID: 2828118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of autolysis on the structure of chicken calpain II.
    Crawford C; Willis AC; Gagnon J
    Biochem J; 1987 Dec; 248(2):579-88. PubMed ID: 2829834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of active calpain by affinity chromatography on an immobilized peptide inhibitor.
    Anagli J; Vilei EM; Molinari M; Calderara S; Carafoli E
    Eur J Biochem; 1996 Nov; 241(3):948-54. PubMed ID: 8944787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of native p94, a muscle-specific calpain, and characterization of its autolysis.
    Kinbara K; Ishiura S; Tomioka S; Sorimachi H; Jeong SY; Amano S; Kawasaki H; Kolmerer B; Kimura S; Labeit S; Suzuki K
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):589-96. PubMed ID: 9794799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and identification of two putative autolytic sites in human calpain 3 (p94) expressed in heterologous systems.
    Federici C; Eshdat Y; Richard I; Bertin B; Guillaume JL; Hattab M; Beckmann JS; Strosberg AD; Camoin L
    Arch Biochem Biophys; 1999 Mar; 363(2):237-45. PubMed ID: 10068445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of monoclonal antibodies specific for the 28-kDa subunit on catalytic properties of the calpains.
    Cong J; Thompson VF; Goll DE
    J Biol Chem; 1993 Dec; 268(34):25740-7. PubMed ID: 7503986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale purification of porcine calpain I and calpain II and comparison of proteolytic fragments of their subunits.
    Kitahara A; Sasaki T; Kikuchi T; Yumoto N; Yoshimura N; Hatanaka M; Murachi T
    J Biochem; 1984 Jun; 95(6):1759-66. PubMed ID: 6088477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyclonal antisera specific for the proenzyme form of each calpain.
    Croall DE; Slaughter CA; Wortham HS; Skelly CM; DeOgny L; Moomaw CR
    Biochim Biophys Acta; 1992 May; 1121(1-2):47-53. PubMed ID: 1599950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-activated neutral proteases (calpains) are carbohydrate binding proteins.
    Zimmerman UJ; Schlaepfer WW
    J Biol Chem; 1988 Aug; 263(24):11609-12. PubMed ID: 2841330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic-site characteristics of the porcine calpain II 80 kDa/18 kDa heterodimer revealed by selective reaction of its essential thiol group with two-hydronic-state time-dependent inhibitors: evidence for a catalytic site Cys/His interactive system and an ionizing modulatory group.
    Mellor GW; Sreedharan SK; Kowlessur D; Thomas EW; Brocklehurst K
    Biochem J; 1993 Feb; 290 ( Pt 1)(Pt 1):75-83. PubMed ID: 8439300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural modifications associated with the change in Ca2+ sensitivity on activation of m-calpain.
    Brown N; Crawford C
    FEBS Lett; 1993 May; 322(1):65-8. PubMed ID: 8482370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid analysis of human von Willebrand factor fragments cleaved by porcine calpain II.
    Nozaki H
    Tokai J Exp Clin Med; 1987 Nov; 12(4):223-7. PubMed ID: 2845608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein for Lp82 calpain is expressed and enzymatically active in young rat lens.
    Ma H; Shih M; Hata I; Fukiage C; Azuma M; Shearer TR
    Exp Eye Res; 1998 Aug; 67(2):221-9. PubMed ID: 9733588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of mu-calpain, m-calpain, and calpastatin from animal tissues.
    Thompson VF; Goll DE
    Methods Mol Biol; 2000; 144():3-16. PubMed ID: 10818742
    [No Abstract]   [Full Text] [Related]  

  • 19. Limited degradation of carbamoyl phosphate synthetase I by calcium-activated protease (calpain): electrophoretic evidence for removal of the C-terminal N-acetylglutamate regulatory domain.
    Makowski GS; Ramsby ML
    Res Commun Mol Pathol Pharmacol; 1999 Mar; 103(3):295-310. PubMed ID: 10509740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and structural characterization of porcine L-threonine dehydrogenase.
    Kao YC; Davis L
    Protein Expr Purif; 1994 Oct; 5(5):423-31. PubMed ID: 7827500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.